Aug. 22 at 5:13 PM
$ELV down 14.1% YTD — time to reconsider your portfolio? 🤔
🔍 Trading at a forward P/E of 9.62, below the industry average of 15.16, with a Value Score of A
📉 However, a Zacks Rank #5 (Strong Sell) and a projected 8.8% earnings decline for 2025 raise red flags.
Complete risk/reward breakdown here 👉 https://www.zacks.com/stock/news/2741798/can-elevance-healths-value-based-care-strategy-fuel-long-term-growth?cid=sm-stocktwits-2-2741798-body-9191&ADID=SYND_STOCKTWITS_TWEET_2_2741798_BODY_9191